Switch to:
More From Other Websites
Sangamo BioSciences Gets FDA Approval For IND For ZFN-Mediated Genome Editing Treatment Of MPS II Jun 20 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated... Jun 20 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated... Jun 20 2016
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jun 15 2016
Premarket Research Report Covering the Biotech Industry Jun 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK